Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,731 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incidence and potential mechanism of resolved, persistent and newly acquired malapposition three days after implantation of self-expanding or balloon-expandable stents in a STEMI population: insights from optical coherence tomography in the APPOSITION II study.
Nakatani S, Onuma Y, Ishibashi Y, Karanasos A, Regar E, Garcia-Garcia HM, Tamburino C, Fajadet J, Vrolix M, Witzenbichler B, Eeckhout E, Spaulding C, Reczuch K, La Manna A, Spaargaren R, Capodanno D, Van Langenhove G, Verheye S, Serruys PW, van Geuns RJ. Nakatani S, et al. Among authors: ishibashi y. EuroIntervention. 2015 Dec;11(8):885-94. doi: 10.4244/EIJY15M11_01. EuroIntervention. 2015. PMID: 26549374 Free article. Clinical Trial.
Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study.
Diletti R, Karanasos A, Muramatsu T, Nakatani S, Van Mieghem NM, Onuma Y, Nauta ST, Ishibashi Y, Lenzen MJ, Ligthart J, Schultz C, Regar E, de Jaegere PP, Serruys PW, Zijlstra F, van Geuns RJ. Diletti R, et al. Among authors: ishibashi y. Eur Heart J. 2014 Mar;35(12):777-86. doi: 10.1093/eurheartj/eht546. Epub 2014 Jan 6. Eur Heart J. 2014. PMID: 24394380 Free article.
Lessons learned from acute and late scaffold failures in the ABSORB EXTEND trial.
Ishibashi Y, Onuma Y, Muramatsu T, Nakatani S, Iqbal J, Garcia-Garcia HM, Bartorelli AL, Whitbourn R, Abizaid A, Serruys PW; ABSORB EXTEND Investigators. Ishibashi Y, et al. EuroIntervention. 2014 Aug;10(4):449-57. doi: 10.4244/EIJV10I4A78. EuroIntervention. 2014. PMID: 24469426 Free article. Clinical Trial.
Temporal evolution of strut light intensity after implantation of bioresorbable polymeric intracoronary scaffolds in the ABSORB cohort B trial-an application of a new quantitative method based on optical coherence tomography.
Nakatani S, Onuma Y, Ishibashi Y, Eggermont J, Zhang YJ, Campos CM, Cho YK, Liu S, Dijkstra J, Reiber JH, Perkins L, Sheehy A, Veldhof S, Rapoza R, van Es GA, Garcia-Garcia HM, van Geuns RJ, Serruys PW; ABSORB Cohort B investigators. Nakatani S, et al. Among authors: ishibashi y. Circ J. 2014;78(8):1873-81. doi: 10.1253/circj.cj-14-0143. Epub 2014 Jun 18. Circ J. 2014. PMID: 24942012 Free article. Clinical Trial.
Fast virtual functional assessment of intermediate coronary lesions using routine angiographic data and blood flow simulation in humans: comparison with pressure wire - fractional flow reserve.
Papafaklis MI, Muramatsu T, Ishibashi Y, Lakkas LS, Nakatani S, Bourantas CV, Ligthart J, Onuma Y, Echavarria-Pinto M, Tsirka G, Kotsia A, Nikas DN, Mogabgab O, van Geuns RJ, Naka KK, Fotiadis DI, Brilakis ES, Garcia-Garcia HM, Escaned J, Zijlstra F, Michalis LK, Serruys PW. Papafaklis MI, et al. Among authors: ishibashi y. EuroIntervention. 2014 Sep;10(5):574-83. doi: 10.4244/EIJY14M07_01. EuroIntervention. 2014. PMID: 24988003 Free article.
Simultaneous occlusion of left anterior descending and left circumflex arteries by very late stent thrombosis: vascular response to drug-eluting stents assessed by intravascular ultrasound.
Yamawaki M, Onuma Y, Nakano M, Muramatsu T, Nakatani S, Ishibashi Y, Ishimori H, Hirano K, Ito Y, Tsukahara R, Muramatsu T. Yamawaki M, et al. Among authors: ishibashi y. Heart Vessels. 2015 Nov;30(6):824-9. doi: 10.1007/s00380-014-0545-0. Epub 2014 Jul 17. Heart Vessels. 2015. PMID: 25031154
In vitro validation and comparison of different software packages or algorithms for coronary bifurcation analysis using calibrated phantoms: implications for clinical practice and research of bifurcation stenting.
Ishibashi Y, Grundeken MJ, Nakatani S, Iqbal J, Morel MA, Généreux P, Girasis C, Wentzel JJ, Garcia-Garcia HM, Onuma Y, Serruys PW. Ishibashi Y, et al. Catheter Cardiovasc Interv. 2015 Mar;85(4):554-63. doi: 10.1002/ccd.25618. Epub 2014 Nov 21. Catheter Cardiovasc Interv. 2015. PMID: 25059819
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial.
Serruys PW, Chevalier B, Dudek D, Cequier A, Carrié D, Iniguez A, Dominici M, van der Schaaf RJ, Haude M, Wasungu L, Veldhof S, Peng L, Staehr P, Grundeken MJ, Ishibashi Y, Garcia-Garcia HM, Onuma Y. Serruys PW, et al. Among authors: ishibashi y. Lancet. 2015 Jan 3;385(9962):43-54. doi: 10.1016/S0140-6736(14)61455-0. Epub 2014 Sep 14. Lancet. 2015. PMID: 25230593 Clinical Trial.
1,731 results